Literature DB >> 7091151

Natural history of "silent" lupus nephritis.

W M Bennett, E J Bardana, D J Norman, D C Houghton.   

Abstract

Twenty patients with systemic lupus erythematosus but without evident renal involvement previously underwent percutaneous renal biopsy. Findings revealed almost universal pathologic evidence of nephritis. Included were three patients who had diffuse proliferative changes and five who had subendothelial electron dense deposits. Only four patients developed clinical renal disease during the follow-up period while no patient died or required dialysis. Using the Life Table Method, the cumulative percentage of patients free from any clinical renal disease was over 60% at 10 yr from the time of diagnosis of systemic lupus, and at 8 yr from the time of the original biopsy. It is concluded that silent lupus nephritis, regardless of histologic subtype, has a favorable prognosis. These data may not be applicable to patients with similar biopsies who have evidence of clinical lupus nephritis.

Entities:  

Mesh:

Year:  1982        PMID: 7091151     DOI: 10.1016/s0272-6386(82)80007-3

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  3 in total

1.  Low-Level Proteinuria in Systemic Lupus Erythematosus.

Authors:  Alice Chedid; Giovanni M Rossi; Francesco Peyronel; Steven Menez; Mohamed G Atta; Serena M Bagnasco; Lois J Arend; Avi Z Rosenberg; Derek M Fine
Journal:  Kidney Int Rep       Date:  2020-09-18

2.  The potential diagnostic utility of coexpression of Ki-67 and P53 in the renal biopsy in pediatric lupus nephritis.

Authors:  Mahtab H Rahbar; Maryam R Rahbar; Nyousha Mardanpour; Sourena Mardanpour
Journal:  Int J Nephrol Renovasc Dis       Date:  2018-12-12

3.  Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis.

Authors:  Oh Chan Kwon; Jung Hwan Park; Hyeong-Cheon Park; Seung Min Jung; Sang-Won Lee; Jason Jungsik Song; Yong-Beom Park; Min-Chan Park
Journal:  Arthritis Res Ther       Date:  2020-06-09       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.